New developments in the treatment of psoriasis.
Rogers
S
S
D000287:Administration, Topical; D003524:Cyclosporins / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D009539:Nicotinic Acids / Q000627:therapeutic use; D011701:PUVA Therapy; D011565:Psoriasis / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D012106:Research; D012176:Retinoids / Q000627:therapeutic use
D003524:Cyclosporins; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D009539:Nicotinic Acids; D012176:Retinoids; C086827:tazarotene